Assembly-private panel discussion gains no fruit

Published: 2011-11-03 07:00:00

Updated: 2011-11-03 07:00:00

Lawmakers of the National Assembly’s Health and Welfare Committee and four law and patent experts held a public hearing on Monday over the impacts that its free trade deals with the U.S. would cause in domestic pharmaceutical sector in the future, but unfortunately it ended with no outcomes.

T...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK